Randomized, Multicentric and Prospective Clinical Trial to Check the Cost-effectiveness of Corifollitropin Alfa vs. Recombinant FSH and/or HP-hMG

Trial Profile

Randomized, Multicentric and Prospective Clinical Trial to Check the Cost-effectiveness of Corifollitropin Alfa vs. Recombinant FSH and/or HP-hMG

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Corifollitropin alfa (Primary) ; Menotropin; Recombinant follicle-stimulating hormone
  • Indications Female infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2015 to 1 Dec 2015.
    • 16 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Jun 2015 to 1 Sep 2015.
    • 25 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top